Abstract:Heart failure (HF) is a globally prevalent cardiovascular disease, but effective drug targets and diagnostic models are still lacking. This study was designed to investigate effective drug targets and diagnostic models for HF in terms of miRNA targets, hoping to contribute to the understanding and treatment of HF. Using HF miRNA and gene expression profile data from the GEO database, we analyzed differentially expressed miRNAs/gene identification in HF using Limma and predicted miRNA targets by the online TargetScan database. Subsequently, gene set enrichment analysis and annotation were performed using WebGestaltR package. Protein-protein interactions were identified using the STRING database. The proximity of drugs to treat HF was also calculated and predicted for potential target therapeutic drug. In addition, further drug identification was performed by molecular docking. Finally, diagnostic models were constructed based on differential miRNAs. The GEO dataset was used to screen 66 differentially expressed miRNAs, incorporating 56 downregulated miRNAs and 10 upregulated miRNAs. The JAK-STAT signaling pathway, MAPK signaling pathway, p53 signaling pathway, Prolactin signaling pathway, and TGF-beta signaling pathway were enriched, as shown by KEGG enrichment analysis on the target genes. In addition, we found that 83 genes were upregulated and 92 genes were downregulated in HF patients vs. healthy individuals. Based on the inflammation-related score, hypoxia-related score, and energy metabolism-related score, we identified key miRNA-mRNA pairs and constructed an interaction network. Following that, TAP1, which had the highest expression and network connectivity in acute HF with crystal and molecular docking studies, was selected as a key candidate gene in the network. And the compound DB04847 was selected to produce a large number of favorable interactions with TAP1 protein. Finally, we constructed two diagnostic models based on the differential miRNAs hsa-miR-6785-5p and hsa-miR-4443. In conclusion, we identified TAP1, a key candidate gene in the diagnosis and treatment of HF, and determined that compound DB04847 is highly likely to be a potential inhibitor of TAP1. The TAP1 gene was also found to be regulated by hsa-miR-6785-5p and hsa-miR-4443, and a diagnostic model was constructed. This provides a new promising direction to improve the diagnosis, prognosis, and treatment outcome and guide more effective immunotherapy strategies of HF.

Electronic Clinical Guideline Embedded Heart Failure Treatment Model

Fast Parameters Estimation in Medication Efficacy Assessment Model for Heart Failure Treatment

A Computational Model for Heart Failure Stratification

A Study of Mechanical Optimization Strategy for Cardiac Resynchronization Therapy Based on an Electromechanical Model

Computer aided embedded medical system and clinical treatment effect of heart failure based on clinical data

New models for heart failure care delivery

A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data

Stratifying heart failure patients with graph neural network and transformer using Electronic Health Records to optimize drug response prediction

Enhancing heart failure treatment decisions: interpretable machine learning models for advanced therapy eligibility prediction using EHR data

Mining Potential Drug Targets and Constructing Diagnostic Models for Heart Failure Based on Mirna-Mrna Networks

Artificial Neural Network Based Model for Cardiovascular Risk Stratification in Hypertension.

Understanding Heart-Failure Patients EHR Clinical Features via SHAP Interpretation of Tree-Based Machine Learning Model Predictions

A novel hybrid modeling approach for the evaluation of integrated care and economic outcome in heart failure treatment

A Heart Failure Diagnosis Model Based on Support Vector Machine

Machine learning-based model for worsening heart failure risk in Chinese chronic heart failure patients

Construction of a Non-Mutually Exclusive Decision Tree for Medication Recommendation of Chronic Heart Failure

A Model for the Prediction of Mortality and Hospitalization in Chinese Heart Failure Patients

Elements of artificial intelligence in a predictive personalized model of pharmacotherapy choice in patients with heart failure with mildly reduced ejection fraction of ischemic origin

Prediction of cardiac deterioration in acute heart failure patients: Evaluation of the efficacy of single laboratory indicator models versus comprehensive models

Care models for patients with heart failure at home: A systematic review

Construction of a TCM and Western combination model for prognostic evaluation of chronic heart failure based on TCM syndrome elements and machine learning